I am excited to announce that TotalCare, the next generation telemedicine platform, has now added comprehensive chronic disease management features. Patients can now use TotalCare for self-management of their chronic conditions. Their providers can also view vitals, both in a tabular and graphical format, to help them better manage their chronic conditions! ...
Business communications service provider Atlantech Online today announced the availability of atlantech|wireless, a unique Mobile Unified Communications service enabling businesses to mobile-enable their company communications. ...
GLEN BURNIE, MD, October 16, 2020 – Vision Technologies, Inc. (Vision), a leading network integrator with national and global reach, announces a financial solution for unanticipated return-to-work (RTW) investments. The Protection as a Services (PaaS) solution is a subscription-based agreement with low monthly payments that encompasses the design, build, and support of security solutions. These services allow businesses to focus on their mission instead of worrying about the technology or upfront capital needed to secure work environments. ...
Unleashed Technologies is once again the leading B2B firm in Maryland.
As the top firm in the state, the digital and web services company outranked a wide variety of B2B firms, including custom software development, branding, design, and more. Criteria for this award include brand reputation, client reviews, and industry expertise.
Clutch is the leading ratings and reviews platform. Each month, over half a million buyers and sellers use Clutch, and the user base keeps growing. ...
GYEONGGI-DO, South Korea & GAITHERSBURG, Md.–(BUSINESS WIRE)–D&D Pharmatech, Inc. (D&D), a clinical-stage biotechnology company focused on development and commercialization of revolutionary medicines, today announced the launch of their fourth subsidiary, Valted Seq. D&D Pharmatech is also the parent company of Neuraly, Precision Molecular, and Theraly Fibrosis. Read More ...
September 16, 2020, Frederick, Maryland – Kemp Proteins, a leading provider of gene-to-protein and monoclonal antibody development services, today announced its decision to use environmentally friendly coolers when shipping protein products to our clients. Kemp Proteins will replace EPS containers with Lifoam’s Envirocooler-EVG insulation, a move that demonstrates the commitment of Kemp’s management team to implement environmentally friendly principles. Read More Here ...
ELKRIDGE, Md., Sept. 18, 2020 /PRNewswire/ — Atlantic Data Forensics (ADF) today announced the Cybersecurity Association of Maryland, Inc. (CAMI), Maryland’s only nonprofit organization dedicated to bolstering the growth of the state’s cybersecurity industry, awarded ADF as Cyber Defender of the Year in the 2020 MD Cybersecurity Awards. The MD Cybersecurity Awards Event recognizes leading-edge cybersecurity product and services companies headquartered in Maryland for their innovations and contributions to the state’s cybersecurity ecosystem. ...
GLEN BURNIE, MD, September 11, 2020 – Vision Technologies, Inc. (Vision), a leading network integrator with national and global reach, is helping companies prepare for employees to return to work safely and securely. Vision’s Touchless Visual Communication and Collaboration (TVCC) solutions are designed to create a safe and secure touchless meeting experience where people can communicate and collaborate seamlessly and with ease with in the room, remotely, or both. Room system and digital signage solutions enable organizations to reinforce occupancy and social distancing policies and share important real-time health and safety information from a range of integrated solutions. With a comprehensive TVCC solution in place, organizations can prepare their staff for a safe, secure and productive return to work. ...
GlycoT Therapeutics has signed a sublicense agreement for its glycoengineering technology with Daiichi Sankyo.
The agreement grants Daiichi Sankyo worldwide and nonexclusive rights to intellectual property that GlycoT currently licenses from the University of Maryland system. The deal includes an undisclosed upfront payment, annual fees, and royalties on sales of GlycoT.
The enzymatic glycoengineering technology platform allows scientists to precisely change and modify the sugars on monoclonal antibodies. Daiichi Sankyo plans to use the technology in the development of new drug candidates. ...